Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial

John H. Stone; Thomas Neumann; Helen Spotswood; Sebastian H. Unizony; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C. Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Robert Spiera; Min Bao

Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial

John H. Stone, Thomas Neumann, Helen Spotswood, Sebastian H. Unizony, Martin Aringer, Daniel Blockmans, Elisabeth Brouwer, Maria C. Cid, Bhaskar Dasgupta, Juergen Rech, Carlo Salvarani, Robert Spiera, Min Bao

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	5S-5S
Aantal pagina's	1
Tijdschrift	Swiss medical weekly
Status	Published - 28-aug-2020

Citeer dit

Stone, J. H., Neumann, T., Spotswood, H., Unizony, S. H., Aringer, M., Blockmans, D., Brouwer, E., Cid, M. C., Dasgupta, B., Rech, J., Salvarani, C., Spiera, R., & Bao, M. (2020). Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial. Swiss medical weekly, 5S-5S.

Stone, John H. ; Neumann, Thomas ; Spotswood, Helen ; Unizony, Sebastian H. ; Aringer, Martin ; Blockmans, Daniel ; Brouwer, Elisabeth ; Cid, Maria C. ; Dasgupta, Bhaskar ; Rech, Juergen ; Salvarani, Carlo ; Spiera, Robert ; Bao, Min. / Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering : 3-Year Results From a Randomized Controlled Phase 3 Trial. In: Swiss medical weekly. 2020 ; blz. 5S-5S.

@article{3097a9323adc4a46a7ff173d4aea061f,

title = "Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial",

author = "Stone, {John H.} and Thomas Neumann and Helen Spotswood and Unizony, {Sebastian H.} and Martin Aringer and Daniel Blockmans and Elisabeth Brouwer and Cid, {Maria C.} and Bhaskar Dasgupta and Juergen Rech and Carlo Salvarani and Robert Spiera and Min Bao",

year = "2020",

month = aug,

day = "28",

language = "English",

pages = "5S--5S",

journal = "Swiss medical weekly",

issn = "1424-7860",

publisher = "E M H SWISS MEDICAL PUBLISHERS LTD",

}

Stone, JH, Neumann, T, Spotswood, H, Unizony, SH, Aringer, M, Blockmans, D, Brouwer, E, Cid, MC, Dasgupta, B, Rech, J, Salvarani, C, Spiera, R & Bao, M 2020, 'Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results From a Randomized Controlled Phase 3 Trial', Swiss medical weekly, blz. 5S-5S.

Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering : 3-Year Results From a Randomized Controlled Phase 3 Trial. / Stone, John H.; Neumann, Thomas; Spotswood, Helen; Unizony, Sebastian H.; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C.; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Spiera, Robert; Bao, Min.

In: Swiss medical weekly, 28.08.2020, blz. 5S-5S.

Onderzoeksoutput › Academic

TY - JOUR

T1 - Time to Flare in Patients With New-Onset Versus Relapsing Giant Cell Arteritis Treated With Tocilizumab or Placebo Plus Prednisone Tapering

T2 - 3-Year Results From a Randomized Controlled Phase 3 Trial

AU - Stone, John H.

AU - Neumann, Thomas

AU - Spotswood, Helen

AU - Unizony, Sebastian H.

AU - Aringer, Martin

AU - Blockmans, Daniel

AU - Brouwer, Elisabeth

AU - Cid, Maria C.

AU - Dasgupta, Bhaskar

AU - Rech, Juergen

AU - Salvarani, Carlo

AU - Spiera, Robert

AU - Bao, Min

PY - 2020/8/28

Y1 - 2020/8/28

M3 - Meeting Abstract

SP - 5S-5S

JO - Swiss medical weekly

JF - Swiss medical weekly

SN - 1424-7860

ER -